Search results
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 6 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
My Novavax stock price forecast was correct: what next now? | Invezz
Invezz· 20 hours agoNovavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the...
Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S.
Market Watch· 7 days agoFrench pharmaceutical company Sanofi said that the priority review date in the U.S. for its chronic obstructive pulmonary disease treatment, Dupixent has ...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via Yahoo News· 7 days agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 6 days agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
Data needed to forge the link between AI and mRNA
Pharmaceutical Technology via Yahoo Finance· 14 hours agoIn recent months, the company has made investments in this space in different ways. Last month, Sanofi announced a deal with Formation Bio and OpenAI,...
Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
Zacks via Yahoo Finance· 9 hours agoSanofi is currently conducting a phase II study of the UC treatment candidate. How Have Estimates......
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 3 days agoIn 2022, the judge in the MDL case referenced by GSK, which also implicated Pfizer, Sanofi and Boehringer Ingleheim, rejected the prospect of a full...
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type...
Morningstar· 7 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by three months the target ...
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
CNBC· 3 days agoCompany logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain...